Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication

• Príomhchruthaitheoirí: Ilona Bereczki (Údar), Henrietta Papp (Údar), Anett Kuczmog (Údar), Mónika Madai (Údar), Veronika Nagy (Údar), Attila Agócs (Údar), Gyula Batta (Údar), Márton Milánkovits (Údar), Eszter Ostorházi (Údar), Ana Mitrović (Údar), Janko Kos (Údar), Áron Zsigmond (Údar), István Hajdú (Údar), Zsolt Lőrincz (Údar), Dávid Bajusz (Údar), György Miklós Keserű (Údar), Jan Hodek (Údar), Jan Weber (Údar), Ferenc Jakab (Údar), Pál Herczegh (Údar), Anikó Borbás (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2021-10-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

The protracted global COVID-19 pandemic urges the development of new drugs against the causative agent SARS-CoV-2. The clinically used glycopeptide antibiotic, teicoplanin, emerged as a potential antiviral, and its efficacy was improved with lipophilic modifications. This prompted us to prepare new...